These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18602879)

  • 1. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.
    Streeten EA; McBride D; Puffenberger E; Hoffman ME; Pollin TI; Donnelly P; Sack P; Morton H
    Bone; 2008 Sep; 43(3):584-90. PubMed ID: 18602879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.
    Streeten EA; Ramirez S; Eliades M; Jaimungal S; Chandrasekaran S; Kathleen R; Holmes Morton D; Puffenberger EG; Herskovitz R; Leonard MB
    Bone; 2015 Aug; 77():17-23. PubMed ID: 25892485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Celli M; D'Eufemia P; Persiani P; Turchetti A; Febbo A; D'Alfonso Y; Celli L; Zambrano A
    Osteoporos Int; 2017 Nov; 28(11):3277-3280. PubMed ID: 28866852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Abdel-Hamid MS; Elhossini RM; Otaify GA; Abdel-Ghafar SF; Aglan MS
    Osteoporos Int; 2022 Jul; 33(7):1501-1510. PubMed ID: 35106624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of growth, puberty, osteoporosis, and the response to long-term bisphosphonate therapy in four patients with osteoporosis-pseudoglioma syndrome.
    Karakilic-Ozturan E; Altunoglu U; Ozturk AP; Kardelen Al AD; Yavas Abali Z; Avci S; Wollnik B; Poyrazoglu S; Bas F; Uyguner ZO; Kayserili H; Darendeliler F
    Am J Med Genet A; 2022 Jul; 188(7):2061-2070. PubMed ID: 35393770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
    Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
    Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Bayram F; Tanriverdi F; Kurtoğlu S; Atabek ME; Kula M; Kaynar L; Keleştimur F
    J Pediatr Endocrinol Metab; 2006 Mar; 19(3):275-9. PubMed ID: 16607930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
    Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
    Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.
    Biha N; Ghaber SM; Hacen MM; Collet C
    Case Rep Genet; 2016; 2016():9814928. PubMed ID: 26904320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Homozygous Nonsense Mutation in the
    Heidari A; Homaei A; Saffari F
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):318-323. PubMed ID: 34965700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and management of osteoporosis-pseudoglioma syndrome.
    Levasseur R
    Expert Rev Endocrinol Metab; 2008 May; 3(3):337-348. PubMed ID: 30754200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report.
    Homaei A; Chegini V; Saffari F
    Int J Endocrinol Metab; 2022 Apr; 20(2):e121031. PubMed ID: 35993038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
    Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
    Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
    Ai M; Heeger S; Bartels CF; Schelling DK;
    Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
    Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
    Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.